• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Headache (1880); Hemorrhage, Subarachnoid (1893); Vascular Dissection (3160)
Event Type  Injury  
Event Description
Information received from the article: jones et al.Prevention of stent thrombosis with reduced dose of prasugrel in two patients undergoing treatment of cerebral aneurysms with pipeline embolisation devices.Bmj case reports 2012.Medtronic (covidien) received information through literature review regarding manufactured product and the adverse event involved with it.Five days post procedure involving two overlapping pipelines, the patient experienced severe headaches and was found to have a small right frontal subarachnoid bleed over the convexity remote from the aneurysm.Prior to the adverse event and during the initial procedure, repeat angiography revealed cervical petrous dissection with flow limitation and an acculink stent was deployed across the dissection.Final angiography demonstrated stent patency and significant stasis within the aneurysm.After the patient complained of the headaches and the bleed was found, repeat cerebral angiography displayed significant aneurysm thrombosis when compared with previous 3d prior.The patient was continued on dual antiplatelet therapy during hospitalization and received 6 months of dual antiplatelet therapy after discharge.The treatment was for a giant aneurysm located in the cavernous segment of the right ica (internal carotid artery).No further complications were reported.
 
Manufacturer Narrative
The report was created to capture the post procedure complications.The information was received from the article: jones et al.Prevention of stent thrombosis with reduced dose of prasugrel in two patients undergoing treatment of cerebral aneurysms with pipeline embolisation devices.(b)(4).The lot history record review was not possible as the lot number was not reported.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE EMBOLIZATION DEVICE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
9775 toledo way
irvine, CA 92618
9496801224
MDR Report Key4547333
MDR Text Key5511447
Report Number2029214-2015-00206
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 01/27/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/27/2015
Initial Date FDA Received02/25/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Disability;
Patient Age50 YR
-
-